Trial Condition(s):

Healthy

Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation

Bayer Identifier:

15854

ClinicalTrials.gov Identifier:

NCT01430533

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The purpose of this study is to determine the dermal sensitization potential of azelaic acid pre-foam formulation.

Inclusion Criteria
- healthy volunteers
- male or female subjects
- aged 18 - 65 years
- ability to understand and fulfill the study requirements
Exclusion Criteria
- affected skin in designated test area
- pregnancy or lactation
- not willing to comply with study requirements

Trial Summary

Enrollment Goal
240
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Finacea® (azelaic acid) Foam, 15% (Azelaic Acid, BAY39-6251)
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Robert I. Cooper, MD

Fargo, United States, 58104

Status
Completed
 

Trial Design